Sino Biopharmaceutical | 1177 - Sales Revenues

Stock Price
5.30
Daily Change
-0.09 -1.67%
Monthly
-10.92%
Yearly
30.54%
Q2 Forecast
5.22

Sino Biopharmaceutical reported CNY14.26B in Sales Revenues for its fiscal semester ending in December of 2025.





Sales Change Date
Akebia Therapeutics USD 57.62M 1.14M Dec/2025
Alaunos Therapeutics USD 2K 2K Mar/2025
Avita Medical AUD 17.61M 805K Dec/2025
Cspc Pharmaceutical CNY 6.11B 502.75M Dec/2025
Dianthus Therapeutics USD 284K 112K Dec/2025
Ionis Pharmaceuticals USD 246M 43M Mar/2026
IQVIA Holdings USD 4.15B 210M Mar/2026
Jiangsu Hengrui CNY 8.14B 300M Mar/2026
Moderna USD 389M 289M Mar/2026
Organon & Co USD 1.46B 50M Mar/2026
Revvity USD 711M 61.06M Mar/2026
Sino Biopharmaceutical CNY 14.26B 3.31B Dec/2025
Tectonic Therapeutic USD 0 0 Dec/2024
Viatris USD 3.52B 180M Mar/2026
Xeris Pharmaceuticals USD 83.13M 2.68M Mar/2026